96 related articles for article (PubMed ID: 24251328)
21. Determination of ketorolac in blood and plasma samples by high-performance liquid chromatography.
Flores-Murrieta FJ; Granados-Soto V; Hong E
Boll Chim Farm; 1994 Oct; 133(9):588-91. PubMed ID: 7848629
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
Shi JM; Lai SG; Xu CJ; Duan GL; Li D
Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
[TBL] [Abstract][Full Text] [Related]
23. Determination of ketorolac in human plasma by reversed-phase high-performance liquid chromatography using solid-phase extraction and ultraviolet detection.
Wang Z; Dsida RM; Avram MJ
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):383-6. PubMed ID: 11393731
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of an enantioselective HPLC-UV method using Chiralpak AD-H to quantify (+)- and (-)-torcetrapib enantiomers in hamster plasma--application to a pharmacokinetic study.
Trivedi RK; Dubey PK; Mullangi R; Srinivas NR
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):224-30. PubMed ID: 17709304
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and synovial fluid concentrations of flurbiprofen enantiomers in horses: chiral inversion.
Soraci AL; Tapia O; Garcia J
J Vet Pharmacol Ther; 2005 Feb; 28(1):65-70. PubMed ID: 15720517
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective pharmacokinetics of flobufen in rats.
Trejtnar F; Wsol V; Szotakova B; Skalova L; Pavek P; Kuchar M
Chirality; 1999; 11(10):781-6. PubMed ID: 10561708
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a chiral liquid chromatographic method, based on Chiralpak to quantify enantiomers of (+/-)-DRF 2725 in rat plasma: lack of inversion of ragaglitazar (S(-)-DRF 2725) to its antipode in plasma.
Mustafa SS; Trivedi R; Mamidi NV; Mullangi R; Srinivas NR
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):23-30. PubMed ID: 15282089
[TBL] [Abstract][Full Text] [Related]
28. Enantioselective determination of ornidazole in human plasma by liquid chromatography-tandem mass spectrometry on a Chiral-AGP column.
Du J; Ma Z; Zhang Y; Wang T; Chen X; Zhong D
J Pharm Biomed Anal; 2013 Dec; 86():182-8. PubMed ID: 24004635
[TBL] [Abstract][Full Text] [Related]
29. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma.
Jin YX; Tang YH; Zeng S
J Pharm Biomed Anal; 2008 Apr; 46(5):953-8. PubMed ID: 18329215
[TBL] [Abstract][Full Text] [Related]
30. Marked enantioselective protein binding in humans of ketorolac in vitro: elucidation of enantiomer unbound fractions following facile synthesis and direct chiral HPLC resolution of tritium-labelled ketorolac.
Hayball PJ; Holman JW; Nation RL; Massy-Westropp RA; Hamon DP
Chirality; 1994; 6(8):642-8. PubMed ID: 7857775
[TBL] [Abstract][Full Text] [Related]
31. [Determination of lornoxicam in human plasma by LC/MS/MS].
Zeng YL; Chen XY; Zhang YF; Zhong DF
Yao Xue Xue Bao; 2004 Feb; 39(2):132-5. PubMed ID: 15127622
[TBL] [Abstract][Full Text] [Related]
32. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Bucci FA; Waterbury LD
Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits.
Wang M; Liu W; Lu Q; Zeng H; Liu S; Yue Y; Cheng H; Liu Y; Xue M
Retina; 2012; 32(10):2158-64. PubMed ID: 23099451
[TBL] [Abstract][Full Text] [Related]
34. Chiral kinetics and dynamics of ketorolac.
Mroszczak E; Combs D; Chaplin M; Tsina I; Tarnowski T; Rocha C; Tam Y; Boyd A; Young J; Depass L
J Clin Pharmacol; 1996 Jun; 36(6):521-39. PubMed ID: 8809637
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat.
Jett MF; Ramesha CS; Brown CD; Chiu S; Emmett C; Voronin T; Sun T; O'Yang C; Hunter JC; Eglen RM; Johnson RM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1288-97. PubMed ID: 10027870
[TBL] [Abstract][Full Text] [Related]
36. Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis.
Cloesmeijer ME; van Esdonk MJ; Lynn AM; Smits A; Tibboel D; Daali Y; Olkkola KT; Allegaert K; Mian P
Br J Clin Pharmacol; 2021 Mar; 87(3):1443-1454. PubMed ID: 32901947
[TBL] [Abstract][Full Text] [Related]
37. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
[TBL] [Abstract][Full Text] [Related]
38. The pharmacokinetics of intravenous ketorolac in children aged 2 months to 16 years: A population analysis.
McLay JS; Engelhardt T; Mohammed BS; Cameron G; Cohen MN; Galinkin JL; Christians U; Avram MJ; Henthorn TK; Dsida RM; Hawwa AF; Anderson BJ
Paediatr Anaesth; 2018 Feb; 28(2):80-86. PubMed ID: 29266539
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves.
Landoni MF; Lees P
Chirality; 1995; 7(8):586-97. PubMed ID: 8593252
[TBL] [Abstract][Full Text] [Related]
40. Determination of (R)- and (S)-ketoprofen in human plasma by liquid chromatography/tandem mass spectrometry following automated solid-phase extraction in the 96-well format.
Eichhold TH; Bailey RE; Tanguay SL; Hoke SH
J Mass Spectrom; 2000 Apr; 35(4):504-11. PubMed ID: 10797647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
